Mycenax Capacity Update July 2024: Fill/Finish

Mycenax is a biologics CDMO with 20 years of experience in comprehensive biologic development and manufacturing services, from proof-of-concept studies and toxicology studies to clinical trials and market. We offer integrated, phase-appropriate services for drug product development and manufacturing, from formulation development to primary packaging, for mAbs, bi-specific/multi-specific antibodies, enzymes, and recombinant proteins. Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually. We have supported 24 projects in various developmental stages for global markets.